SNDK is now trading at a level where most Street targets look stale, shorts are retreating fast, and options traders are the most defensively positioned they've been all year.
The week's defining move came from Morgan Stanley. Joseph Moore raised his target from $1,100 to $1,750 on Tuesday — a 59% lift — while keeping his Overweight rating. That follows the Barclays upgrade from May 27, covered in the previous note, and a further raise from Susquehanna to $3,250 on May 29. The direction of travel is consistent: every firm that touched the stock in the past two weeks raised targets, and the pace of upward revisions has accelerated. The mean target of $1,493 has been overtaken by the stock itself, which closed at $1,716 on Tuesday — meaning the consensus is now nearly $225 below where the market is trading. EPS momentum factor scores rank in the 98th percentile on a 90-day window, so the revisions cycle is still running, not cooling.
Short positioning tells a notably cleaner story than the options market. Short interest has dropped almost 19% over the past week to 6.3% of free float — a sharp unwind from the ~7.7% level seen in mid-May. That's a material move in a short time, and it aligns with the sharp price rally: is up 8% on the week and 45% over the past month. The lending market is entirely untroubled. Availability is running at nearly 30 shares available for every one currently borrowed — far into the loose end of the range — and cost to borrow is just 0.18%, down sharply from last month despite a week-on-week tick higher. There is no squeeze dynamic here. Shorts are leaving because the trade has moved against them, not because they're being forced out.
Options positioning is the contrarian data point. The put/call ratio has climbed to 1.42 — a 52-week high — and runs nearly two standard deviations above its 20-day average of 1.25. That's a meaningful defensive tilt, especially for a stock still rising on the week. Notably, the PCR has been trending higher for almost a month, from 1.08 at the start of May to Tuesday's record reading. Whether that reflects traders hedging fresh longs after a 45% monthly run or outright bearish bets is hard to disentangle, but the signal is clear: as the stock price has surged, options market participants have been paying more for downside protection, not less.
The institutional register shows the stock is in broadly stable hands. Fidelity (FMR) topped up by 202,000 shares through April, holding 8.9% of shares. BlackRock added 777,000 shares in the same period. Jane Street nearly doubled its position, adding 941,000 shares through March. Goldman built a new position of over 1.1 million shares. The buyer base across Q1 and early Q2 skews toward passive and multi-strategy rather than concentrated active — supportive of price but not the kind of conviction that tends to press an aggressive view.
Insider activity adds a note of caution worth flagging. CEO David Goeckeler sold $2.3 million of stock on May 25 — the same day the CTO and CLO also sold. The CTO, Alper Ilkbahar, was back at the window on June 1, selling a further $3.5 million across three transactions. These are individual trades at elevated prices following a historic run, and they carry ORTEX trade significance scores of 1-3 out of 10. Still, the pattern — C-suite selling into strength, consistently — is on the record as the stock approaches $1,750 and the prior note's observation that targets have been left behind remains true.
The next earnings event is scheduled for August 14. The last print on April 30 produced an 11.5% move the following day and a 26% gain over the subsequent five trading sessions — the clearest single data point explaining why the revisions cycle has been so relentless. What to watch into the next print is whether the gap between the stock price and the mean analyst target begins to close via further target raises or via price consolidation — and whether the defensive options positioning reflects a hedge on existing longs or the beginning of a broader repositioning ahead of August.
See the live data behind this article on ORTEX.
Open SNDK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
